Medica Share Discussion Threads

[soundbuy] 30/8/2017 10:59

Yawn...........

[ayesha4] 30/8/2017 10:38

Neutral position as a holder.

[jgoold] 30/8/2017 10:14

Bought in today. Good niche, cash generation, growth and institutional interest.

[lomax99] 30/8/2017 08:15

Reckon the fall was overdone, and it would not surprise me if they either beat, or came in at the upper end of forecasts. Roll on 18th September.

[glaws2] 30/8/2017 08:13

Berenberg has initiated coverage of Medica Group with a Buy rating, price target 260.00p

[divinessence] 30/8/2017 08:10

What's up doc?

[thebigshortfella] 25/8/2017 22:47

mmc71 - what's your take on the recent share movements? Is it just randomness or is there some "manipulation" going on here? Have a great weekend fella.

[lomax99] 25/8/2017 15:09

Fall overdone, added.

[mmc71] 25/8/2017 12:57

Not sure its a tree shake. Level 2 shows more sells on the order book. In fact the only buy orders are at 195p and there is currently only one MM holding the bid at 200p.

[steve3sandal] 24/8/2017 15:14

I was intending to wait upon results given the rating, but I saw today's chat and down 10p, had a few more also.

[lomax99] 24/8/2017 12:28

Think you are right, I am adding.

[thebigshortfella] 24/8/2017 12:22

Call me cynical but I suspect today's volatility is MM's trying to relieve investors of their shares by triggering their stops...

[divinessence] 23/8/2017 10:53

thebigshortfella ... I am looking to add soon as trying release funds. I think it will motor fairly quickly judging from the recent trades.
Yeritz made a couple of good points. Much more to come totally agree.
Dan-the_epic is a sceptic, fair enough & no problem but be a constructive one with the right facts.
andyr42 says it as he thinks and is usually on the mark as i've seen him on other threads. I do like his straight talk.

GLA.

[dan_the_epic] 22/8/2017 22:01

Correct; I spent quite a lot of time looking into this so trying to work out if there is something I'm badly missing that would change my mind

[thebigshortfella] 22/8/2017 21:56

Dan_the_Epic - I like the fact that you are challenging MGP. Am I right in assuming that you wouldn't trade MGP at its current share price?

[dan_the_epic] 22/8/2017 21:36

Calm down. No need to go off on one due to a bit of contrary comment (admittedly with a wrong multiple number).

As far as I can tell, the rise since IPO has been entirely multiple expansion, rather than a material increase in expected EPS. That multiple expansion is sentiment based so it is absolutely fundamentally fair to question that multiple.

"Fund managers like HL are not stupid, they know far more than you and me"

I agree with some of what you said, but definitely not this. Some fund managers, I guarantee, know less than a well informed PI about their investments.

[yertiz] 22/8/2017 20:11

This is a company that has found a niche market in the NHS - mark my words it is not the only market available, I mentioned before there are several other opportunities to be explored, not only within radiography but pathology services too. Now we are on to a market I have been involved in for many years (40 +) and it has to change, perhaps by outsourcing histology and cytology examinations, point of care (diabetic and coagulation clinics) results and clinical advice services, and the bread and butter of all hospital pathology - biochemistry, haematology and immunoassay. All could be outsourced to some extent and Medica has stolen the march on any potential competitors, making this company the trendsetter and an exciting prospect to boot. I'm a long term holder and looking to increase my holding at every opportunity. £3 would be very nice, but the potential is much bigger!

[lomax99] 22/8/2017 19:47

I'm going to double my holding if we hit Dan's £1.50! Lol.

[thebigshortfella] 22/8/2017 19:39

Divinessence - I am long also & don't disagree with what you wrote.

I am keen to understand your thinking. Are you saying that you will buy more MGP if it is trading above £3? If so, why not add more now? Or are you implying you are going to add now?

[divinessence] 22/8/2017 18:21

There is no way this business is coming back in-house whatever the party in power. This business will grow and grow through further outsorucing deals in other areas. I know many doctors and physicians and they all tell me there is no resource, NHS is on its back. I can see it trading over £3 not too long after the interims. I will probably add as a connsequence.

[divinessence] 22/8/2017 13:13

Big buys going through again. Fund managers must be buying, have been for a while now it would appear? I am trying to get excited for the interims!

[andyr42] 22/8/2017 12:25

All the facts and figures are there. This Dan (the Un_Epic) chap is talking rubbish and doesn't know how business works. Best ignore people like that as they add no value. Glass is always EMPTY with this lot. On your bike fella. MGP is a fantastic business, almost a coup to print money with huge growth prospects imo. I agree comment about HL and their investment portfolio. £3+ by eoy.

[divinessence] 22/8/2017 12:12

It's up 50% because the business has moved on. As mentioned they have the infrastructure in place for growth without the cost. Market looks forward NOT backwards. Fund managers like HL are not stupid, they know far more than you and me. Don't buy if you are not convinced, sell if you are not sure. But this is what SCW had to say in its full coverage of MGP May 2017 ...

"There are
only four decent sized UK competitors but Medica
is 3x bigger than the No.2 (Radiology Reporting).
As Medica was the first entrant it was initially able
to command high pricing and despite most of the
contracts being repriced in 2014, gross margin per
interpretation is still 49.8% (gross margin has
always been c50% or better) but Medica’s offsetting
coup is that electronic efficiencies have greatly
improved radiologist productivity and its large scale
means operating margin lifted from an already
mouthwatering 26.6% in 2015 to 28.5% in 2016.
2017 has started with a bang and Medica is
working with 99 of the 190 Acute Trusts, up from
92 a year ago (no one is over 7% of sales). It is also
set to launch new services such as mammography
(breast imaging), colonography (bowel cancer) and
PET scans (to show how body tissues are
working). I remain a buyer. It looks a fabulous
business with a glittering future."

[dan_the_epic] 22/8/2017 10:02

I don't doubt the story, but the valuation here is what I'm trying to get to the bottom of with this helpful discussion. I have read the SCSW piece but the gripe I normally have is that the financials are not covered in depth

I'd buy the story, but this is up over 50% on the IPO price so valuation needs to be tight.

[mysteronz] 22/8/2017 09:24

No problem, glad to post it but it was highlighted by a previous poster here so cant take credit. Good to see some discussion on this thread :)